Strength
150 mg/mL
Manufacturer
Amphastar Pharmaceuticals, Inc.NDC
00548541025
Classification
Generic
Dosage Form
INJECTION, SUSPENSION, EXTENDED RELEASE
Route
INTRAMUSCULAR
Last Updated
4/23/2025
Active Ingredients
MEDROXYPROGESTERONE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA077235On Market Since
11/28/2017
Pharmacological Classes
Progesterone Congeners
Progestin
Related Drugs
Same classification
NORETHINDRONE 0.35 MG TABLET
Generic
00378727253•Mylan Pharmaceuticals Inc.
$0.0922
per EA
NORETHINDRONE 0.35 MG TABLET
Generic
00378729253•Mylan Pharmaceuticals Inc.
$0.0922
per EA
NORA-BE TABLET
Generic
00480347516•Teva Pharmaceuticals USA Inc.
$0.0922
per EA
LYLEQ 0.35 MG TABLET
Generic
50102030013•Afaxys Pharma, LLC
$0.0922
per EA
CAMILA 0.35 MG TABLET
Generic
51862088403•Mayne Pharma
$0.0922
per EA
ERRIN 0.35 MG TABLET
Generic
51862088603•Mayne Pharma
$0.0922
per EA
NORA-BE TABLET
Generic
52544062928•Actavis Pharma, Inc.
$0.0922
per EA
EMZAHH 0.35 MG TABLET
Generic
59651013628•Aurobindo Pharma Limited
$0.0922
per EA
EMZAHH 0.35 MG TABLET
Generic
59651013688•Aurobindo Pharma Limited
$0.0922
per EA
INCASSIA 0.35 MG TABLET
Generic
65862092528•Aurobindo Pharma Limited
$0.0922
per EA